These benefits are reflected in the clinical guidelines published by the American Diabetes Association (ADA) and the American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE), which recommend use of a GLP-1RA or a sodium-glucose co-transporter-2 inhibitor (SGLT2i) with demonstrated CV risk reduction in patients with established/high risk of atherosclerotic CVD (ASCVD), while considering patient-specific factors [15, 17]
All clinical decisions belong to the patient and an independent licensed prescriber
If you're gonna use a GLP one and we're gonna say, Hey, keep your muscle mass, make sure you work out
If your abdominal pain is severe or you have signs of dehydration, such as dizziness or trouble urinating, call your doctors office right away
But it wasnt until the 1940s that nitrogen mustard (a derivative of mustard gas) was first used to treat a patient with blood cancer
Following publication of these new study results, Lilly indicated that it anticipates the Food and Drug Administration will make a regulatory decision as early as the end of this year. Industry analysts expect that makers of other weight-loss drugs will soon turn their attention to OSA, too